We are live on
!
Find out more
SI
Sofinnova Investments Portfolio holdings
AUM
$2B
1-Year Est. Return
127.65%
This Fund
S&P 500
1 Year Est. Return
+127.65%
AUM
$2B
AUM Growth
-$323M
(-14%)
Holding
84
Top Buys
| 1 | +$69M | |
| 2 | +$42.3M | |
| 3 | +$34.6M | |
| 4 |
Alcon
ALC
|
+$31.7M |
| 5 |
Insmed
INSM
|
+$29.1M |
Top Sells
| 1 | +$191M | |
| 2 | +$74.6M | |
| 3 | +$72.6M | |
| 4 |
Intuitive Surgical
ISRG
|
+$71.9M |
| 5 |
Eli Lilly
LLY
|
+$66.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$31B
| $310M | 15.53% |
1,550,280
|
|
||
2
Bristol-Myers Squibb
BMY
$114B
| $121M | 6.04% |
1,988,721
+475,727
|
|
||
3
Jazz Pharmaceuticals
JAZZ
$14.4B
| $113M | 5.67% |
598,327
-361,533
|
|
||
4
Vera Therapeutics
VERA
$2.27B
| $112M | 5.63% |
2,793,987
|
|
||
5
United Therapeutics
UTHR
$23.1B
| $94.9M | 4.76% |
160,070
+2,429
|
|
||
6
AstraZeneca
AZN
$278B
| $89.9M | 4.51% |
456,031
-1,176,303
|
|
||
7
Cogent Biosciences
COGT
$5.36B
| $81.4M | 4.08% |
2,113,551
+139,926
|
|
||
8
Ultragenyx Pharmaceutical
RARE
$2.26B
| $65.9M | 3.3% |
3,145,888
+3,062,588
|
|
||
|
RAPP
9
Rapport Therapeutics
RAPP
$1.68B
| $59.6M | 2.99% |
1,904,408
|
|
||
|
10
Insmed
INSM
$19.9B
| $56.6M | 2.84% |
346,075
+189,274
|
|
||
|
11
Alcon
ALC
$32.2B
| $55M | 2.76% |
729,972
+397,452
|
|
||
12
Supernus Pharmaceuticals
SUPN
$2.62B
| $49.3M | 2.47% |
954,309
+401,214
|
|
||
13
BioMarin Pharmaceuticals
BMRN
$10.9B
| $44.2M | 2.21% |
781,982
+84,849
|
|
||
14
Biogen
BIIB
$28.7B
| $42.1M | 2.11% |
+229,521
|
|
||
15
Celcuity
CELC
$4.3B
| $41.8M | 2.09% |
366,175
+66,758
|
|
||
|
BIOA
16
BioAge Labs
BIOA
$688M
| $40.1M | 2.01% |
2,293,788
|
|
||
17
Rhythm Pharmaceuticals
RYTM
$5.88B
| $39.1M | 1.96% |
450,096
+178,702
|
|
||
18
ArriVent BioPharma
AVBP
$1.42B
| $39.1M | 1.96% |
1,696,752
|
|
||
19
IDEAYA Biosciences
IDYA
$2.46B
| $37.7M | 1.89% |
1,131,786
+246,665
|
|
||
20
Immunome
IMNM
$2.06B
| $37.2M | 1.86% |
1,701,904
+83,427
|
|
||
21
Nektar Therapeutics
NKTR
$1.92B
| $36.7M | 1.84% |
509,546
+70,916
|
|
||
22
Axsome Therapeutics
AXSM
$12.7B
| $36M | 1.8% |
212,747
+200,481
|
|
||
23
Immatics
IMTX
$1.21B
| $35.7M | 1.79% |
3,630,454
+194,912
|
|
||
24
BridgeBio Pharma
BBIO
$13.2B
| $30.4M | 1.52% |
409,183
-311,265
|
|
||
25
Dyne Therapeutics
DYN
$2.92B
| $29.6M | 1.48% |
1,633,897
-620,264
|
|